Scientific poster: 3D iPSC-derived cardiac microtissues for drug discovery
This scientific poster describes the generation of iPSC-derived 3D cardiac microtissues and their amenability for high throughput screening.
TAKE THE FIRST STEP
ABOUT US
Predict future safety and efficacy more efficiently
For more than a decade, Ncardia has been pioneering innovations in human induced pluripotent stem cells (iPSC). Our iPSC drug discovery platforms have been successfully leveraged by large biopharmas, up-and-coming drug discovery firms and multinational research consortia to advance therapeutic candidates for cardiovascular, neurological and other disease areas.